Matthew Beasley
Papers
1
Total Citations
18
H-Index
1
About
Dr. Matthew Beasley is a leading clinical researcher in head and neck oncology, with a focused expertise in human papillomavirus (HPV)-positive oropharyngeal cancer. His major contribution lies in pioneering de-escalation treatment strategies designed to reduce long-term toxicities without compromising survival. As the principal investigator of the landmark PATHOS trial, Dr. Beasley has advanced a risk-stratified, reduced-intensity adjuvant approach following transoral surgery, aiming to preserve quality of life for patients with HPV-positive disease. This work, cited 18 times, addresses the critical challenge of mitigating the severe side effects of traditional therapies in a patient population with otherwise excellent prognosis. Dr. Beasley’s research has been instrumental in shifting the paradigm toward personalized, less morbid treatment protocols in head and neck cancer. His ongoing efforts continue to shape clinical guidelines and inspire a new generation of oncologists to prioritize both cure and survivorship.
Research Focus
Key Achievements
Top Papers
- 1